Rights and permissions
About this article
Cite this article
Twice-daily temozolomide effective for recurrent glioma. Inpharma Wkly. 1634, 18 (2008). https://doi.org/10.2165/00128413-200816340-00043
Published:
Issue Date:
DOI: https://doi.org/10.2165/00128413-200816340-00043